Explore

Streams

About Index

Index

By TNW

Fidelity Biosciences

2023

Fidelity Biosciences

They are a division of Fidelity Investments, one of the world's leading providers of financial services.

Follow us

Also headquartered in London

Companies in the same industry

Terms of Service Privacy Policy Cookie Statement

Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 25

Portfolio

Portfolio Tracker

Blueprint Medicines to buy cancer drug startup with potential edge over Takeda, J&J targeted therapies

Former Iora Health execs raise $13M to guide seniors through Medicare enrollment

Molekule Air Mini and Novaerus Protect 200 review: Killing more than pollutants

$2,100,000,000

One Medical (ONEM) Announces Deal To Buy Iora Health In $2.1 Billion Deal: Details

FDA green-lights second RET inhibitor, this time from Blueprint Medicines

$30,000,000 Venture capital

,

Kyruus Raises $30M in Funding

PremjiInvest leads large funding round in US-based Iora Health

$126,000,000 Venture capital (Series F)

,

Iora Health Completes $126M Series F Funding Round

Why Ivenix wants to create the next-generation of infusion pumps

$60,000,000 Venture capital (Series D)

,

Quartet raises $60M Series D led by Centene

Recent departures hint at turmoil at Quartet Health, a mental health startup backed by GV

Funding Employment

TraceLink Bags $93M, Plans A.I. & Blockchain Tools for Drug Tracking

Funding Manufacturing Cloud

TraceLink just landed $60 million more to eliminate counterfeit prescription drugs

Funding Health

$100,000,000 Venture capital (Series E)

Iora Health Goes Big With $100M to Advance Collaborative Care Model

Health Funding

Iora Health Secures $100M in Series E Financing

Funding Health

Quartet Health CEO: The case for intertwining primary care and behavioral health

$10,000,000 Venture capital

Health IT startup Kyruus brings in $10M to support matching patients with providers

Boston Tech Watch: Kyruus, Kolide, Nano-C, BookingBug

Funding

$69,200,000 IPO

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health